FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kanneganti Murthy

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabó
The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.
Dirk M. Maybauer; Marc O Maybauer; Csaba Szabó; Martin Westphal; Lillian D Traber; Perenlei Enkhbaatar; Kanneganti G K Murthy; Yoshimitsu Nakano; Andrew L Salzman; David N Herndon; Daniel L Traber
Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity.
Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabó
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kanneganti Murthy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabó
The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.
Shock (Augusta, Ga.) 2009;32(3):258-62.
2008: Dirk M. Maybauer; Marc O Maybauer; Csaba Szabó; Martin Westphal; Lillian D Traber; Perenlei Enkhbaatar; Kanneganti G K Murthy; Yoshimitsu Nakano; Andrew L Salzman; David N Herndon; Daniel L Traber
Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity.
Biochemical and biophysical research communications 2008;377(3):786-91.
2008: Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabó
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.
The Journal of endocrinology 2008;198(3):581-9.
2005: Jon G Mabley; Eszter M Horváth; Kanneganti G K Murthy; Zsuzsanna Zsengellér; Anne Vaslin; Rita Benko; Márk Kollai; Csaba Szabó
Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.
The Journal of pharmacology and experimental therapeutics 2005;315(2):812-20.
2005: Lewis F Neville; Yoav Barnea; Orly Hammer-Munz; Eyal Gur; Boris Kuzmenko; Hamutal Kahel-Raifer; Rachel Eren; Adi Elkeles; Kanneganti G K Murthy; Csaba Szabó; Andrew L Salzman; Shlomo Dagan; Yehuda Carmeli; Shiri Navon-Venezia
Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection.
International journal of molecular medicine 2005;16(1):165-71.
2004: Kanneganti G K Murthy; Chun-Yang Xiao; Jon G Mabley; Min Chen; Csaba Szabó
Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
Shock (Augusta, Ga.) 2004;21(3):230-4.
2004: Kanneganti G K Murthy; Amitabha Deb; Sunali Goonesekera; Csaba Szabó; Andrew L Salzman
Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro.
The Journal of biological chemistry 2004;279(7):5667-75.
2003: Lucas Liaudet; Csaba Szabó; Oleg V Evgenov; Kanneganti G K Murthy; Pal Pacher; Laszlo Virag; Jon G Mabley; Anita Marton; Francisco Soriano; Mikhail Y Kirov; Lars J Bjertnaes; Andrew L Salzman
Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis.
Shock (Augusta, Ga.) 2003;19(2):131-7.
2002: Kevin Ryan; Kanneganti G K Murthy; Syuzo Kaneko; James L Manley
Requirements of the RNA polymerase II C-terminal domain for reconstituting pre-mRNA 3' cleavage.
Molecular and cellular biology 2002;22(6):1684-92.
2002: Lucas Liaudet; Kanneganti G K Murthy; Jon G Mabley; Pal Pacher; Francisco Soriano; Andrew L Salzman; Csaba Szabó
Comparison of inflammation, organ damage, and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide.
Infection and immunity 2002;70(1):192-8.
2001: Anita Marton; Pal Pacher; Kanneganti G K Murthy; Z H Németh; György Haskó; Csaba Szabó
Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro.
International journal of molecular medicine 2001;8(6):617-21.
2001: Laszlo Virag; Prakash Jagtap; E Szabó; Francisco Soriano; Lucas Liaudet; Anita Marton; D G Hoyt; Kanneganti G K Murthy; Andrew L Salzman; Garry J Southan; Csaba Szabó
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.
Nature medicine 2001;7(1):108-13.
2000: Raul Mendez; Kanneganti G K Murthy; Kevin Ryan; James L Manley; Joel D Richter
Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex.
Molecular cell 2000;6(5):1253-9.
1998: D F Colgan; Kanneganti G K Murthy; W Zhao; Carol Prives; James L Manley
Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites.
The EMBO journal 1998;17(4):1053-62.
1998: L Jayaraman; N C Moorthy; Kanneganti G K Murthy; James L Manley; M Bustin; Carol Prives
High mobility group protein-1 (HMG-1) is a unique activator of p53.
Genes & development 1998;12(4):462-72.
1997: JC Dantonel; Kanneganti G K Murthy; James L Manley; Làszlò Tora
Transcription factor TFIID recruits factor CPSF for formation of 3' end of mRNA.
Nature 1997;389(6649):399-402.
1997: L Jayaraman; Kanneganti G K Murthy; C Zhu; T Curran; S Xanthoudakis; Carol Prives
Identification of redox/repair protein Ref-1 as a potent activator of p53.
Genes & development 1997;11(5):558-70.
1996: D F Colgan; Kanneganti G K Murthy; Carol Prives; James L Manley
Cell-cycle related regulation of poly(A) polymerase by phosphorylation.
Nature 1996;384(6606):282-5.
1995: Kanneganti G K Murthy; James L Manley
The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3'-end formation.
Genes & development 1995;9(21):2672-83.
1994: T Raabe; Kanneganti G K Murthy; James L Manley
Poly(A) polymerase contains multiple functional domains.
Molecular and cellular biology 1994;14(5):2946-57.
1992: Kanneganti G K Murthy; James L Manley
Characterization of the multisubunit cleavage-polyadenylation specificity factor from calf thymus.
The Journal of biological chemistry 1992;267(21):14804-11.
1991: Kanneganti G K Murthy; P Park; James L Manley
A nuclear micrococcal-sensitive, ATP-dependent exoribonuclease degrades uncapped but not capped RNA substrates.
Nucleic acids research 1991;19(10):2685-92.